These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2982955)

  • 41. Complement-fixing antibody to the AG-4 antigen in herpes simplex virus type 2-infected patients.
    Arsenakis M; May JT
    Infect Immun; 1981 Jul; 33(1):22-8. PubMed ID: 6266964
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of ultraviolet irradiation of the skin on herpes simplex virus infection: alteration in immune function mediated by epidermal cells and in the course of infection.
    Otani T; Mori R
    Arch Virol; 1987; 96(1-2):1-15. PubMed ID: 3039943
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
    Wassilew SW; Koch I
    Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.
    Glorioso J; Kees U; Kümel G; Kirchner H; Krammer PH
    J Immunol; 1985 Jul; 135(1):575-82. PubMed ID: 2582051
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. III. Analysis of viral glycoproteins recognized by CTL clones by using recombinant herpes simplex viruses.
    Yasukawa M; Zarling JM
    J Immunol; 1985 Apr; 134(4):2679-82. PubMed ID: 2579149
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protein analysis of herpes simplex virus latency in vitro established with cycloheximide.
    Shiraki K; Rapp F
    Virology; 1989 Sep; 172(1):346-9. PubMed ID: 2549718
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lymphocyte stimulation by herpes simplex virus (HSV) antigens. 1. Culture conditions, cell fractionation and presentation of HSV antigens.
    Kapoor AK; Ling NR; Bazeley M
    Cytobios; 1977; 20(79-80):151-62. PubMed ID: 216529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Determination of herpes simplex virus type-specific antibodies by solid-phase RIA on Helix pomatia lectin-purified antigens.
    Suchánková A; Hirsch I; Krĕmár M; Vonka V
    J Infect Dis; 1984 Jun; 149(6):964-72. PubMed ID: 6330240
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Characterization of "modified-self"-induced specific antibody hyporesponsiveness to herpes simplex virus.
    Wilson LA; Thompson JJ; Ohkawa S; Scott DW
    Viral Immunol; 1992; 5(2):113-22. PubMed ID: 1377470
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequency of herpes simplex virus-specific cytotoxic T lymphocyte precursors in lymph node cells of infected mice.
    Rouse BT; Wagner H
    Immunology; 1984 Jan; 51(1):57-64. PubMed ID: 6317545
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Zwitterionic detergent solubilisation of HSV-1 surface antigens.
    Jennings R; Quasim T; Sharrard RM; Hockley D; Potter CW
    Arch Virol; 1988; 98(3-4):137-53. PubMed ID: 2831853
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cell-mediated immunity in herpes simplex virus-infected mice: suppression of delayed hypersensitivity by an antigen-specific B lymphocyte.
    Nash AA; Gell PG
    J Gen Virol; 1980 Jun; 48(Pt 2):359-64. PubMed ID: 6249886
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A reproducible method for the optimum infection of human mononuclear cells and lymphoid cell lines by herpes simplex virus type 1.
    Mahan KB; Hoffmann PJ; Hoffmann CC
    J Virol Methods; 1982 Mar; 4(2):63-75. PubMed ID: 6281288
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
    Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
    J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Immune response to herpes simplex virus in patients with recurrent herpes labialis. II. Relationship between interferon production and cytotoxic responses.
    Tsutsumi H; Bernstein JM; Riepenhoff-Talty M; Ogra PL
    Pediatr Res; 1986 Sep; 20(9):905-8. PubMed ID: 3018660
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibitory effect of herpes simplex virus infection to target cells on recognition of minor histocompatibility antigens by cytotoxic T lymphocytes.
    Kuzushima K; Isobe K; Morishima T; Takatsuki A; Nakashima I
    J Immunol; 1990 Jun; 144(12):4536-40. PubMed ID: 2161874
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
    Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
    J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lymphocyte blast transformation response of seropositive and seronegative subjects to herpes simplex, rubella, mumps and measles virus antigens.
    Ilonen J
    Acta Pathol Microbiol Scand C; 1979 Apr; 87C(2):151-7. PubMed ID: 220840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.